Sang W. Shin

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 54 publications

Molecular and clinical disparity of EGFR-mutant non-small cell lung cancer (NSCLC) based on histopathological stage and EGFR molecular subtypes.

Molecular and clinical disparity of EGFR-mutant non-small cell lung cancer (NSCLC) based on histopathological stage and EGFR molecular subtypes.

Journal: Translational lung cancer research

Published: November 26, 2025

Unveiling the clinical impact of plasma-only mutations in non-small cell lung cancer: a Korean multicenter experience.

Unveiling the clinical impact of plasma-only mutations in non-small cell lung cancer: a Korean multicenter experience.

Journal: Translational lung cancer research

Published: July 10, 2025

Wearable Digital Health Technologies in Clinical Care.

Wearable Digital Health Technologies in Clinical Care.

Journal: The New England journal of medicine

Published: June 12, 2024

Navigating and Communicating about Serious Illness and End of Life.

Navigating and Communicating about Serious Illness and End of Life.

Journal: The New England journal of medicine

Published: April 10, 2024

Radiological safety assessment for transportation of reactor pressure vessel during decommissioning of a nuclear power plant in Korea.

Radiological safety assessment for transportation of reactor pressure vessel during decommissioning of a nuclear power plant in Korea.

Journal: Journal of radiological protection : official journal of the Society for Radiological Protection

Published: December 04, 2023

Lazertinib versus Gefitinib as First-Line Treatment for EGFR-mutated Locally Advanced or Metastatic NSCLC: LASER301 Korean Subset.

Lazertinib versus Gefitinib as First-Line Treatment for EGFR-mutated Locally Advanced or Metastatic NSCLC: LASER301 Korean Subset.

Journal: Cancer research and treatment

Published: March 09, 2023

Tumor-Infiltrating Lymphocyte Therapy in Advanced Melanoma.

Tumor-Infiltrating Lymphocyte Therapy in Advanced Melanoma.

Journal: The New England journal of medicine

Published: March 01, 2023

Randomized Trial of Tepotinib Plus Gefitinib versus Chemotherapy in EGFR-Mutant NSCLC with EGFR Inhibitor Resistance Due to MET Amplification: INSIGHT Final Analysis.

Randomized Trial of Tepotinib Plus Gefitinib versus Chemotherapy in EGFR-Mutant NSCLC with EGFR Inhibitor Resistance Due to MET Amplification: INSIGHT Final Analysis.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: November 13, 2022

Comparison of the Data of a Next-Generation Sequencing Panel from K-MASTER Project with That of Orthogonal Methods for Detecting Targetable Genetic Alterations.

Comparison of the Data of a Next-Generation Sequencing Panel from K-MASTER Project with That of Orthogonal Methods for Detecting Targetable Genetic Alterations.

Journal: Cancer research and treatment

Published: February 15, 2021

Significance of descriptive symptoms and signs and clinical parameters as predictors of neuropathic cancer pain.

Significance of descriptive symptoms and signs and clinical parameters as predictors of neuropathic cancer pain.

Journal: PloS one

Published: October 26, 2020

The Clinical Significance of RAS, PIK3CA, and PTEN Mutations in Non-Small Cell Lung Cancer Using Cell-Free DNA.

The Clinical Significance of RAS, PIK3CA, and PTEN Mutations in Non-Small Cell Lung Cancer Using Cell-Free DNA.

Journal: Journal of clinical medicine

Published: July 21, 2020

Innovative countermeasures can maintain cancer care continuity during the coronavirus disease-2019 pandemic in Korea.

Innovative countermeasures can maintain cancer care continuity during the coronavirus disease-2019 pandemic in Korea.

Journal: European journal of cancer (Oxford, England : 1990)

Published: June 05, 2020

Showing 1-12 of 54

Last Updated: 09/26/2026